BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14568969)

  • 1. Transcriptional regulation of type I diabetes by NF-kappa B.
    Lamhamedi-Cherradi SE; Zheng S; Hilliard BA; Xu L; Sun J; Alsheadat S; Liou HC; Chen YH
    J Immunol; 2003 Nov; 171(9):4886-92. PubMed ID: 14568969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation.
    Artis D; Shapira S; Mason N; Speirs KM; Goldschmidt M; Caamaño J; Liou HC; Hunter CA; Scott P
    J Immunol; 2002 Oct; 169(8):4481-7. PubMed ID: 12370384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-intrinsic expression of NF-kappa B1 is required to promote optimal Th2 cell differentiation.
    Artis D; Kane CM; Fiore J; Zaph C; Shapira S; Joyce K; Macdonald A; Hunter C; Scott P; Pearce EJ
    J Immunol; 2005 Jun; 174(11):7154-9. PubMed ID: 15905559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii.
    Mason NJ; Liou HC; Hunter CA
    J Immunol; 2004 Mar; 172(6):3704-11. PubMed ID: 15004174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
    Artis D; Speirs K; Joyce K; Goldschmidt M; Caamaño J; Hunter CA; Scott P
    J Immunol; 2003 Feb; 170(4):1995-2003. PubMed ID: 12574369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner.
    Zelazowski P; Shen Y; Snapper CM
    Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
    Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
    J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
    Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA
    J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice.
    Ramakrishnan P; Yui MA; Tomalka JA; Majumdar D; Parameswaran R; Baltimore D
    Diabetes; 2016 Aug; 65(8):2367-79. PubMed ID: 27217485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
    Rao S; Gerondakis S; Woltring D; Shannon MF
    J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity.
    Finn PW; He H; Ma C; Mueller T; Stone JR; Liou HC; Boothby MR; Perkins DL
    J Leukoc Biol; 2002 Nov; 72(5):1054-62. PubMed ID: 12429729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles for the NF-kappaB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals.
    O'Keeffe M; Grumont RJ; Hochrein H; Fuchsberger M; Gugasyan R; Vremec D; Shortman K; Gerondakis S
    Blood; 2005 Nov; 106(10):3457-64. PubMed ID: 16037393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells.
    Grumont RJ; Rourke IJ; O'Reilly LA; Strasser A; Miyake K; Sha W; Gerondakis S
    J Exp Med; 1998 Mar; 187(5):663-74. PubMed ID: 9480976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis.
    Campbell IK; Gerondakis S; O'Donnell K; Wicks IP
    J Clin Invest; 2000 Jun; 105(12):1799-806. PubMed ID: 10862795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell development and survival require distinct NF-kappaB subunits.
    Ouaaz F; Arron J; Zheng Y; Choi Y; Beg AA
    Immunity; 2002 Feb; 16(2):257-70. PubMed ID: 11869686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation.
    Donovan CE; Mark DA; He HZ; Liou HC; Kobzik L; Wang Y; De Sanctis GT; Perkins DL; Finn PW
    J Immunol; 1999 Dec; 163(12):6827-33. PubMed ID: 10586083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of essential role of NF-kappa B p50, RelA, and cRel subunits in virus-induced type 1 IFN expression.
    Wang X; Hussain S; Wang EJ; Wang X; Li MO; García-Sastre A; Beg AA
    J Immunol; 2007 Jun; 178(11):6770-6. PubMed ID: 17513724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pathways for NF-kappa B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains.
    Liu J; Beller DI
    J Immunol; 2003 May; 170(9):4489-96. PubMed ID: 12707325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defective NF-kappa B/RelB pathway in autoimmune-prone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells.
    Valéro R; Baron ML; Guérin S; Béliard S; Lelouard H; Kahn-Perles B; Vialettes B; Nguyen C; Imbert J; Naquet P
    J Immunol; 2002 Jul; 169(1):185-92. PubMed ID: 12077244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.